4
Changes in Ownership
NEKTAR THERAPEUTICS Filed Acc 0001209191-19-050149
SVP & Chief Financial Officer sold 25,000 shares at $20.52 ($513,000)
- SVP & Chief Financial Officer acquired 25,000 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Labrucherie Gil M SVP & Chief Financial Officer | 2019-09-16 | Option exercise | +25,000 | $7.21 | $180,250 | 177,872 | D |
| Labrucherie Gil M SVP & Chief Financial Officer | 2019-09-16 | Sale | −25,000 | $20.52 | $513,000 | 152,872 | D |
| Derivatives | |||||||
| Labrucherie Gil M SVP & Chief Financial Officer | 2019-09-16 | Option exercise · Stock Option | −25,000 | 50,000 | D | ||
| Open-market sales · 25,000 sh · avg $20.52 · $513,000 | |||||||
Loading xslF345X03/doc4.xml…